Your browser doesn't support javascript.
loading
Completely resolved advanced biliary tract cancer after treatment by pembrolizumab: a report of two cases.
Alshari, Osama M; Dawaymeh, Tamara A; Tashtush, Nour A; Aleshawi, Abdelwahab J; Al Manasra, Abdel Rahman A; Obeidat, Khaled A.
Afiliação
  • Alshari OM; Departments of Internal Medicine.
  • Dawaymeh TA; Departments of Internal Medicine.
  • Tashtush NA; Departments of Internal Medicine.
  • Aleshawi AJ; Departments of General Surgery, Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
  • Al Manasra ARA; Departments of General Surgery, Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
  • Obeidat KA; Departments of General Surgery, Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Onco Targets Ther ; 12: 5293-5298, 2019.
Article em En | MEDLINE | ID: mdl-31308699
ABSTRACT
Biliary tract cancers (BTC) represent an aggressive disease with a dismal prognosis. Gemcitabine in combination with cisplatin is the standard first-line palliative treatment for advanced BTC. There is no established treatment following progression on gemcitabine-cisplatin. In this article, we present two cases for individuals with advanced BTC who were treated with pembrolizumab and the tumors have completely resolved.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2019 Tipo de documento: Article